TrademarkDir
RNA ACTUATOR
LIVE

Serial Number

97768020

Owner

CAMP4 Therapeutics Corporation

Attorney

Christina M. Licursi

First Use Date

Jan 22, 2025

Filing Date

Jan 25, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RNA ACTUATOR Trademark

Serial Number: 97768020 • Registration: 8170025

RNA ACTUATOR is a trademark filed by CAMP4 Therapeutics Corporation on January 25, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CAMP4 Therapeutics Corporation

One Kendall Square
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

January 25, 2023

Registration Date

March 10, 2026

First Use Anywhere

January 22, 2025

First Use in Commerce

January 22, 2025

Published for Opposition

March 19, 2024

Goods & Services

Biological and chemical agents, namely, chemical preparations for scientific and research use; synthetic nucleic acids other than for medical or veterinary purposes; chemically modified nucleic acids, other than for medical or veterinary purposes; chemicals for use in biotherapeutics in the biochemical and chemical industries and excluding medical and veterinary purpose; biological preparations for use in industry and science; chemical agents, namely, chemical preparations for analyses in laboratories, other than for medical or veterinary purposes

Pharmaceutical, therapeutic pharmaceuticals, and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, namely, enzyme deficiency diseases and disorders, genetic diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, and rare diseases and disorders; nucleic acid-based therapeutic pharmaceuticals and therapeutic agents for the treatment of a variety of human and animal diseases and disorders, namely, enzyme deficiency diseases and disorders, genetic diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, and rare diseases and disorders; chemicals for use in therapeutic product development and manufacturing processes in the medical field

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 19, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 19, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2026 CRFA
ASSIGNED TO LIE
Feb 19, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 3, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 3, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 23, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 18, 2025 AITU
USE AMENDMENT FILED
May 14, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 14, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 6, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 13, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2023 NWOS
NEW APPLICATION ENTERED
Jan 28, 2023 NWAP

Related Trademarks